Search

Your search keyword '"Forconi, Francesco"' showing total 1,036 results
Start Over Author "Forconi, Francesco"
1,036 results on '"Forconi, Francesco"'

102. Continued Long Term Responses to Ibrutinib + Venetoclax Treatment for Relapsed/Refractory CLL in the Blood Cancer UK TAP Clarity Trial

Author

Hillmen, Peter, primary, Boucher, Rebecca H., additional, Webster, Nichola, additional, Dalal, Surita, additional, Brock, Kristian, additional, Yates, Francesca, additional, Sankhalpara, Chhaya, additional, Macdonald, Donald, additional, Fegan, Christopher, additional, McCaig, Alison, additional, Schuh, Anna, additional, Pettitt, Andrew, additional, Gribben, John G., additional, Patten, Piers, additional, Devereux, Stephen, additional, Bloor, Adrian, additional, Fox, Christopher P, additional, Forconi, Francesco, additional, Rawstron, Andrew, additional, and Hillmen, Peter, additional

Published
2020
Full Text
View/download PDF

108. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

Author

Laurenti, Luca, Tarnani, Michela, Nichele, Ilaria, Ciolli, Stefania, Cortelezzi, Agostino, Forconi, Francesco, Rossi, Davide, Mauro, Francesca Romana, DʼArena, Giovanni, Del Poeta, Giovanni, Montanaro, Marco, Morabito, Fortunato, Musolino, Caterina, Callea, Vincenzo, Falchi, Lorenzo, Tedeschi, Alessandra, Ambrosetti, Achille, Gaidano, Gianluca, Leone, Giuseppe, and Foà, Robin

Published
2011
Full Text
View/download PDF

111. BRAF Mutations in Hairy-Cell Leukemia

Author

Tiacci, Enrico, Trifonov, Vladimir, Schiavoni, Gianluca, Holmes, Antony, Kern, Wolfgang, Martelli, Maria Paola, Pucciarini, Alessandra, Bigerna, Barbara, Pacini, Roberta, Wells, Victoria A., Sportoletti, Paolo, Pettirossi, Valentina, Mannucci, Roberta, Elliott, Oliver, Liso, Arcangelo, Ambrosetti, Achille, Pulsoni, Alessandro, Forconi, Francesco, Trentin, Livio, Semenzato, Gianpietro, Inghirami, Giorgio, Capponi, Monia, Di Raimondo, Francesco, Patti, Caterina, Arcaini, Luca, Musto, Pellegrino, Pileri, Stefano, Haferlach, Claudia, Schnittger, Susanne, Pizzolo, Giovanni, Foà, Robin, Farinelli, Laurent, Haferlach, Torsten, Pasqualucci, Laura, Rabadan, Raul, and Falini, Brunangelo

Published
2011

113. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

Author

Rasi, Silvia, Spina, Valeria, Bruscaggin, Alessio, Vaisitti, Tiziana, Tripodo, Claudio, Forconi, Francesco, De Paoli, Lorenzo, Fangazio, Marco, Sozzi, Elisa, Cencini, Emanuele, Laurenti, Luca, Marasca, Roberto, Visco, Carlo, Xu-Monette, Zijun Y., Gattei, Valter, Young, Ken H., Malavasi, Fabio, Deaglio, Silvia, Gaidano, Gianluca, and Rossi, Davide

Published
2011
Full Text
View/download PDF

114. CLL-088: Neutropenia Analysis of Venetoclax Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Pooled Data from VENICE-I and -II Phase 3b Trials

Author

Anderson, Mary Ann, primary, Davids, Matthew S., additional, Kater, Arnon P., additional, Cochrane, Tara, additional, Demirkan, Fatih, additional, Herishanu, Yair, additional, Leber, Brian, additional, Nikitin, Eugene, additional, Masud, Abdullah A., additional, Rosenberg, Tanya S., additional, Sharmokh, Simon, additional, Fort, Stan, additional, and Forconi, Francesco, additional

Published
2020
Full Text
View/download PDF

115. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Author

Condoluci, Adalgisa, primary, Terzi di Bergamo, Lodovico, primary, Langerbeins, Petra, primary, Hoechstetter, Manuela A., primary, Herling, Carmen D., primary, De Paoli, Lorenzo, primary, Delgado, Julio, primary, Rabe, Kari G., primary, Gentile, Massimo, primary, Doubek, Michael, primary, Mauro, Francesca R., primary, Chiodin, Giorgia, primary, Mattsson, Mattias, primary, Bahlo, Jasmin, primary, Cutrona, Giovanna, primary, Kotaskova, Jana, primary, Deambrogi, Clara, primary, Smedby, Karin E., primary, Spina, Valeria, primary, Bruscaggin, Alessio, primary, Wu, Wei, primary, Moia, Riccardo, primary, Bianchi, Elena, primary, Gerber, Bernhard, primary, Zucca, Emanuele, primary, Gillessen, Silke, primary, Ghielmini, Michele, primary, Cavalli, Franco, primary, Stussi, Georg, primary, Hess, Mark A., primary, Baumann, Tycho S., primary, Neri, Antonino, primary, Ferrarini, Manlio, primary, Rosenquist, Richard, primary, Forconi, Francesco, primary, Foà, Robin, primary, Pospisilova, Sarka, primary, Morabito, Fortunato, primary, Stilgenbauer, Stephan, primary, Döhner, Hartmut, primary, Parikh, Sameer A., primary, Wierda, William G., primary, Montserrat, Emili, primary, Gaidano, Gianluca, primary, Hallek, Michael, primary, and Rossi, Davide, primary

Published
2020
Full Text
View/download PDF

116. Neutropenia analysis of venetoclax monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia: Pooled data from VENICE-I and -II Phase IIIb trials.

Author

Anderson, Mary Ann, primary, Davids, Matthew Steven, additional, Kater, Arnon P., additional, Cochrane, Tara, additional, Demirkan, Fatih, additional, Herishanu, Yair, additional, Leber, Brian, additional, Nikitin, Eugene, additional, Masud, Abdullah A., additional, Rosenberg, Tanya S., additional, Sharmokh, Simon, additional, Fort, Stan, additional, and Forconi, Francesco, additional

Published
2020
Full Text
View/download PDF

117. Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells

Author

Lemm, Elizabeth A., primary, Valle-Argos, Beatriz, additional, Smith, Lindsay D., additional, Richter, Johanna, additional, Gebreselassie, Yohannes, additional, Carter, Matthew J., additional, Karolova, Jana, additional, Svaton, Michael, additional, Helman, Karel, additional, Weston-Bell, Nicola J., additional, Karydis, Laura, additional, Williamson, Chris T., additional, Lenz, Georg, additional, Pettigrew, Jeremy, additional, Harwig, Curtis, additional, Stevenson, Freda K., additional, Cragg, Mark, additional, Forconi, Francesco, additional, Steele, Andrew J., additional, Cross, Jennifer, additional, Mackenzie, Lloyd, additional, Klener, Pavel, additional, and Packham, Graham, additional

Published
2020
Full Text
View/download PDF

119. Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL

Author

Kwok, Marwan, primary, Oldreive, Ceri, additional, Rawstron, Andy C., additional, Goel, Anshita, additional, Papatzikas, Grigorios, additional, Jones, Rhiannon E., additional, Drennan, Samantha, additional, Agathanggelou, Angelo, additional, Sharma-Oates, Archana, additional, Evans, Paul, additional, Smith, Edward, additional, Dalal, Surita, additional, Mao, Jingwen, additional, Hollows, Robert, additional, Gordon, Naheema, additional, Hamada, Mayumi, additional, Davies, Nicholas J., additional, Parry, Helen, additional, Beggs, Andrew D., additional, Munir, Talha, additional, Moreton, Paul, additional, Paneesha, Shankara, additional, Pratt, Guy, additional, Taylor, A. Malcolm R., additional, Forconi, Francesco, additional, Baird, Duncan M., additional, Cazier, Jean-Baptiste, additional, Moss, Paul, additional, Hillmen, Peter, additional, and Stankovic, Tatjana, additional

Published
2020
Full Text
View/download PDF

120. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

Author

Rinaldi, Andrea, Forconi, Francesco, Arcaini, Luca, Mian, Michael, Sozzi, Elena, Zibellini, Silvia, Baldini, Luca, Franceschetti, Silvia, Gaidano, Gianluca, Marasca, Roberto, Mollejo, Manuela, Piris, Miguel A., Tucci, Alessandra, Facchetti, Fabio, Bhagat, Govind, Favera, Riccardo D., Rancoita, Paola M. V., Zucca, Emanuele, Kwee, Ivo, and Bertoni, Francesco

Published
2010
Full Text
View/download PDF

122. Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications

Author

Arruga, Francesca, primary, Bracciamà, Valeria, additional, Vitale, Nicoletta, additional, Vaisitti, Tiziana, additional, Gizzi, Katiuscia, additional, Yeomans, Alison, additional, Coscia, Marta, additional, D’Arena, Giovanni, additional, Gaidano, Gianluca, additional, Allan, John N., additional, Furman, Richard R., additional, Packham, Graham, additional, Forconi, Francesco, additional, and Deaglio, Silvia, additional

Published
2019
Full Text
View/download PDF

124. Multicentre Genome Wide Association Study Identifies Risk Alleles for Progressive Chronic Lymphocytic Leukaemia

Author

Allsup, David, primary, Lin, Wei Yu, additional, Fordham, Sarah Elizabeth, additional, Sunter, Nicola, additional, Elstob, Claire, additional, Rahman, Thahira, additional, Willmore, Elaine, additional, Shepherd, Colin, additional, Strathdee, Gordon, additional, Barrow, Timothy, additional, Mainou-Fowler, Tryfonia, additional, Piddock, Rachel, additional, Marr, Helen, additional, Wallis, Jonathan, additional, Marshall, Scott R., additional, Summerfield, Geoffery, additional, Pettitt, Andrew, additional, Pepper, Chris, additional, Fegan, Christopher, additional, Forconi, Francesco, additional, Dyer, Martin J.S., additional, Jayne, Sandrine, additional, Sellors, April, additional, Schuh, Anna, additional, Robbe, Pauline, additional, Oscier, David, additional, Houlston, Richard S., additional, Bailey, James, additional, Rais, Syed Ashar, additional, Bentley, Alison, additional, Cawkwell, Lynn, additional, Hillmen, Peter, additional, Pratt, Guy, additional, and Allan, James M., additional

Published
2019
Full Text
View/download PDF

125. Mannosylation of the Tumor Immunoglobulin Variable Region Informs Cell of Origin and Environmental Interactions in DLBCL Subsets

Author

Chiodin, Giorgia, primary, Allen, Joel, additional, Rock, Philip J, additional, Martino, Enrica Antonia, additional, Valle Argos, Beatriz, additional, Packham, Graham, additional, Duriez, Patrick, additional, Geijtenbeek, Teunis, additional, Figdor, Carl, additional, Burack, Richard, additional, Crispin, Max, additional, Stevenson, Freda K, additional, and Forconi, Francesco, additional

Published
2019
Full Text
View/download PDF

126. High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade during Ibrutinib Therapy in CLL Patients

Author

Chiodin, Giorgia, primary, Dutton, David, additional, Martino, Enrica Antonia, additional, Drennan, Samantha, additional, Tracy, Ian, additional, Ondrisova, Laura, additional, Henderson, Isla, additional, D'Avola, Annalisa, additional, Pitsillidou, Christina, additional, Mraz, Marek, additional, Johnson, Peter, additional, Duncombe, Andrew, additional, Packham, Graham, additional, Steele, Andrew J, additional, Parker, Helen, additional, Bonfiglio, Silvia, additional, Scarfo, Lydia, additional, Sutton, Lesley-Ann, additional, Ghia, Paolo, additional, Rose-Zerilli, Matthew John Jerome, additional, Strefford, Jonathan C, additional, Stevenson, Freda K., additional, and Forconi, Francesco, additional

Published
2019
Full Text
View/download PDF

128. The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia

Author

Eyre, Toby A., primary, Roeker, Lindsey E., additional, Fox, Christopher P., additional, Gohill, Satyen H., additional, Walewska, Renata, additional, Walter, Harriet S., additional, Forconi, Francesco, additional, Broom, Angus, additional, Arumainathan, Arvind, additional, Brander, Danielle M., additional, Allan, John N., additional, Schuster, Stephen J., additional, Hill, Brian T., additional, Lansigan, Frederick, additional, Cheson, Bruce D., additional, Lamanna, Nicole, additional, Coombs, Catherine C., additional, Barr, Paul M., additional, Skarbnik, Alan P., additional, Shadman, Mazyar, additional, Ujjani, Chaitra S., additional, Pearson, Laurie, additional, Pagel, John M., additional, Jacobs, Ryan, additional, and Mato, Anthony R., additional

Published
2019
Full Text
View/download PDF

129. Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

Author

Hillmen, Peter, primary, Rawstron, Andy C., additional, Brock, Kristian, additional, Muñoz-Vicente, Samuel, additional, Yates, Francesca J., additional, Bishop, Rebecca, additional, Boucher, Rebecca, additional, MacDonald, Donald, additional, Fegan, Christopher, additional, McCaig, Alison, additional, Schuh, Anna, additional, Pettitt, Andrew, additional, Gribben, John G., additional, Patten, Piers E.M., additional, Devereux, Stephen, additional, Bloor, Adrian, additional, Fox, Christopher P., additional, Forconi, Francesco, additional, and Munir, Talha, additional

Published
2019
Full Text
View/download PDF

131. Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

Author

Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Rivas, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marcos, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Lukas, Schuh, Anna, Eyre, Toby A, Kennedy, Ben, Bowles, Kris M, Vignetti, Marco, de la Serna, Javier, Moreno, Carol, Foà, Robin, Ghia, Paolo, GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum, Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Riva, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marco, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Luka, Schuh, Anna, Eyre, Toby A., Kennedy, Ben, Bowles, Kris M., Vignetti, Marco, De La Serna, Javier, Moreno, Carol, Foà, Robin, and Ghia, Paolo

Subjects
Oncology, Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study, Salvage therapy, chemistry.chemical_compound, rituximab, 0302 clinical medicine, Piperidines, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, Aged, 80 and over, education.field_of_study, clinical trial, Hematology, Middle Aged, Prognosis, Fludarabine, Treatment Outcome, Italy, 030220 oncology & carcinogenesis, Ibrutinib, Bendamustine, Retreatment, Rituxima, Rituximab, medicine.drug, Chronic Lymphocytic Leukemia, bendamustine, ibrutinib, Adult, medicine.medical_specialty, Population, NO, 03 medical and health sciences, Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, Chemoimmunotherapy, CLL, Bendamustine, Rituxima, prognosis, Hematology, Internal medicine, medicine, Biomarkers, Tumor, Humans, Progression-free survival, education, Aged, Salvage Therapy, business.industry, Adenine, ERIC and UK CLL FORUM study, Leukemia, Lymphocytic, Chronic, B-Cell, Survival Analysis, United Kingdom, Regimen, Pyrimidines, chemistry, chronic lymphocytic leukemia, Pyrazoles, prognosis, business, CLL, 030215 immunology
Abstract

We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PFS) was 25 months. The presence of del (17p), unmutated IGHV and advanced stage were associated with a shorter PFS at multivariate analysis. The median time-to-next treatment was 31.3 months. Front-line treatment with a chemoimmunotherapy regimen was the only predictive factor for a shorter time to next treatment at multivariate analysis. The median overall survival (OS) was 74.5 months. Advanced disease stage (i.e. Rai stage III-IV or Binet stage C) and resistant disease were the only parameters significantly associated with a shorter OS. Grade 3-5 infections were recorded in 6.3% of patients. A matched-adjusted indirect comparison with ibrutinib given second-line within Named Patient Programs in the United Kingdom and in Italy was carried out with OS as objective end point. When restricting the analysis to patients with intact 17p who had received chemoimmunotherapy in first line, there was no difference in OS between patients treated with ibrutinib (63% alive at 36 months) and patients treated with BR (74.4% alive at 36 months). BR is an efficacious first salvage regimen in CLL in a real-life population, including the elderly and unfit patients. BR and ibrutinib may be equally effective in terms of OS when used as first salvage treatment in patients without 17p deletion. (Registered at clinicaltrials.gov identifier: 02491398).

Published
2018

132. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

Author

Rossi, Davide, Sozzi, Elisa, Puma, Alessia, De Paoli, Lorenzo, Rasi, Silvia, Spina, Valeria, Gozzetti, Alessandro, Tassi, Maristella, Cencini, Emanuele, Raspadori, Donatella, Pinto, Valeria, Bertoni, Francesco, Gattei, Valter, Lauria, Francesco, Gaidano, Gianluca, and Forconi, Francesco

Published
2009
Full Text
View/download PDF

134. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

Author

Bomben, Riccardo, Dal Bo, Michele, Capello, Daniela, Forconi, Francesco, Maffei, Rossana, Laurenti, Luca, Rossi, Davide, Del Principe, Maria Ilaria, Zucchetto, Antonella, Bertoni, Francesco, Rossi, Francesca Maria, Bulian, Pietro, Cattarossi, Ilaria, Ilariucci, Fiorella, Sozzi, Elisa, Spina, Valeria, Zucca, Emanuele, Degan, Massimo, Lauria, Francesco, Del Poeta, Giovanni, Efremov, Dimitar G., Marasca, Roberto, Gaidano, Gianluca, and Gattei, Valter

Published
2009

136. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis

Author

Cavazzini, Francesco, Hernandez, Jose Angel, Gozzetti, Alessandro, Russo Rossi, Antonella, De Angeli, Cristiano, Tiseo, Ruana, Bardi, Antonella, Tammiso, Elisa, Crupi, Rosaria, Lenoci, Maria Pia, Forconi, Francesco, Lauria, Francesco, Marasca, Roberto, Maffei, Rossana, Torelli, Giuseppe, Gonzalez, Marcos, Martin-Jimenez, Patricia, Maria Hernandez, Jesus, Rigolin, Gian Matteo, and Cuneo, Antonio

Published
2008

138. BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia

Author

Smith, Lindsay D., Minton, Annabel R., Blunt, Matthew D., Karydis, Laura I., Dutton, David A., Rogers-Broadway, Karly-Rai, Dobson, Rachel, Liu, Rena, Norster, Faith, Hogg, Elizabeth, Ashton-Key, Margaret, Strefford, Jonathan C., Jia, Li, Efremov, Dimitar G., Helgason, G. Vignir, Johnson, Peter W.M., Stevenson, Freda K., Forconi, Francesco, Cragg, Mark S., Tumbarello, David A., Packham, Graham, and Steele, Andrew J.

Subjects
Autophagy, Humans, Receptors, Antigen, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Article, Signal Transduction
Abstract

No abstract available.

Published
2019

144. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia

Author

Bulian Pietro, Rossi Davide, Forconi Francesco, Del Poeta Giovanni, Bertoni Francesco, Zucca Emanuele, Montillo Marco, Pozzato Gabriele, D'Arena Giovanni, Efremov Dimitar G, Marasca Roberto, Lauria Francesco, Gaidano Gianluca, Gattei Valter, and Laurenti Luca

Subjects
Chronic lymphocytic leukaemia, Prognosis, Prognostic score, Nomogram, Medicine
Abstract

Abstract Background Prognostic index for survival estimation by clinical-demographic variables were previously proposed in chronic lymphocytic leukemia (CLL) patients. Our objective was to test in a large retrospective cohort of CLL patients the prognostic power of biological and clinical-demographic variable in a comprehensive multivariate model. A new prognostic index was proposed. Methods Overall survival and time to treatment in 620 untreated CLL patients were analyzed retrospectively to evaluate the multivariate independence and predictive power of mutational status of immunoglobulin heavy chain variable gene segments (IGHV), high-risk chromosomal aberration such as 17p or 11q deletions, CD38 and ZAP-70 expression, age, gender, Binet stage, β2-microglobulin levels, absolute lymphocyte count and number of lymph node regions. Results IGHV mutational status and 17p deletion were the sole biological variables with independent prognostic relevance in a multivariate model for overall survival, which included easily measurable clinical parameters (Binet staging, β2-microglobulin levels) and demographics (age and gender). Analysis of time to treatment in Binet A patients below 70 years of age showed that IGHV was the most important predictor. A novel 6-variable clinical-biological prognostic index was developed and internally validated, which assigned 3 points for Binet C stage, 2 points/each for Binet B stage and for age > 65 years, 1 point/each for male gender, high β2-microglobulin levels, presence of an unmutated IGHV gene status or 17p deletion. Patients were classified at low-risk (score = 0-1; 21%), intermediate-risk (score 2-5; 63% of cases), high-risk (score 6-9; 16% of cases). Projected 5-year overall survival was 98%, 90% and 58% in low-, intermediate- and high-risk groups, respectively. A nomogram for individual patient survival estimation was also proposed. Conclusions Data indicate that IGHV mutational status and 17p deletion may be integrated with clinical-demographic variables in new prognostic tools to estimate overall survival.

Published
2012
Full Text
View/download PDF

145. Acalabrutinib in Patients (pts) with Waldenstrom Macroglobulinemia (WM)

Author

Owen, Roger McCarthy, Helen Rule, Simon D'Sa, Shirley and Thomas, Sheeba K. Forconi, Francesco Anderson, Thomas C. and Kersten, Marie Jose Zinzani, Pier Luigi Iyengar, Sunil and Kothari, Jaimal Minnema, Monique Kastritis, Efstathios and Izumi, Raquel Slatter, J. Greg Mittag, Diana Wei, Helen and Chen, Dih-Yih Patel, Priti Furman, Richard R.

Published
2018

146. International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

Author

Condoluci, Adalgisa, primary, di Bergamo, Lodovico Terzi, additional, Langerbeins, Petra, additional, Hoechstetter, Manuela, additional, Herling, Carmen, additional, De Paoli, Lorenzo, additional, Delgado, Julio, additional, Rabe, Kari G., additional, Gentile, Massimo, additional, Doubek, Michael, additional, Mauro, Francesca Romana, additional, Chiodin, Giorgia, additional, Mattsson, Mattias, additional, Bahlo, Jasmin, additional, Cutrona, Giovanna, additional, Kotaskova, Jana, additional, Deambrogi, Clara, additional, Spina, Valeria, additional, Bruscaggin, Alessio, additional, Moia, Riccardo, additional, Bianchi, Elena, additional, Gerber, Bernhard, additional, Zucca, Emanuele, additional, Ghielmini, Michele, additional, Cavalli, Franco, additional, Stüssi, Georg, additional, Neri, Antonino, additional, Ferrarini, Manlio, additional, Rosenquist, Richard, additional, Forconi, Francesco, additional, Foà, Robin, additional, Pospisilova, Sarka, additional, Morabito, Fortunato, additional, Parikh, Sameer A., additional, Wierda, William G., additional, Montserrat, Emili, additional, Gaidano, Gianluca, additional, Hallek, Michael, additional, and Rossi, Davide, additional

Published
2019
Full Text
View/download PDF

147. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications

Author

Arruga, Francesca, primary, Bracciamà, Valeria, additional, Vitale, Nicoletta, additional, Vaisitti, Tiziana, additional, Gizzi, Katiuscia, additional, Yeomans, Alison, additional, Coscia, Marta, additional, D’Arena, Giovanni, additional, Gaidano, Gianluca, additional, Allan, John N., additional, Furman, Richard R., additional, Packham, Graham, additional, Forconi, Francesco, additional, and Deaglio, Silvia, additional

Published
2019
Full Text
View/download PDF

148. Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

Author

Diop, Fary, primary, Moia, Riccardo, additional, Favini, Chiara, additional, Spaccarotella, Elisa, additional, De Paoli, Lorenzo, additional, Bruscaggin, Alessio, additional, Spina, Valeria, additional, Terzi-di-Bergamo, Lodovico, additional, Arruga, Francesca, additional, Tarantelli, Chiara, additional, Deambrogi, Clara, additional, Rasi, Silvia, additional, Adhinaveni, Ramesh, additional, Patriarca, Andrea, additional, Favini, Simone, additional, Sagiraju, Sruthi, additional, Jabangwe, Clive, additional, Kodipad, Ahad A., additional, Peroni, Denise, additional, Mauro, Francesca R., additional, Giudice, Ilaria Del, additional, Forconi, Francesco, additional, Cortelezzi, Agostino, additional, Zaja, Francesco, additional, Bomben, Riccardo, additional, Rossi, Francesca Maria, additional, Visco, Carlo, additional, Chiarenza, Annalisa, additional, Rigolin, Gian Matteo, additional, Marasca, Roberto, additional, Coscia, Marta, additional, Perbellini, Omar, additional, Tedeschi, Alessandra, additional, Laurenti, Luca, additional, Motta, Marina, additional, Donaldson, David, additional, Weir, Phil, additional, Mills, Ken, additional, Thornton, Patrick, additional, Lawless, Sarah, additional, Bertoni, Francesco, additional, Poeta, Giovanni Del, additional, Cuneo, Antonio, additional, Follenzi, Antonia, additional, Gattei, Valter, additional, Boldorini, Renzo Luciano, additional, Catherwood, Mark, additional, Deaglio, Silvia, additional, Foà, Robin, additional, Gaidano°, Gianluca, additional, and Rossi°, Davide, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results